The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
1 capsule contains 0.25 g of lincomycin hydrochloride, equivalent to lincomycin.
Infections due to microorganisms susceptible to the drug: infections of bones and joints (osteomyelitis, septic arthritis); infections of ENT organs and respiratory tract, otitis, sinusitis, acute bronchitis, pneumonia; purulent skin and soft tissue infections (furunculosis, abscess, infected wound, panaritium, mastitis), erysipelatous inflammation.
If you have information about any adverse effects or other drug-related problems, please fill in the form